| Bid | 48.33 |
| Market Cap | 4.64B |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | -1.35 |
| PE Ratio (ttm) | -58.75 |
| Forward PE | n/a |
| Analyst | Hold |
| Ask | 79.62 |
| Volume | 3,229,252 |
| Avg. Volume (20D) | 1,965,824 |
| Open | 79.35 |
| Previous Close | 79.34 |
| Day's Range | 79.29 - 79.39 |
| 52-Week Range | 36.73 - 79.69 |
| Beta | undefined |
About NARI
Inari Medical, Inc., a medical device company, develops, manufactures, markets, and sells devices for the interventional treatment of venous diseases in the United States. The company provides ClotTriever, a mechanical thrombectomy system, which is designed to core, capture, and remove large clots from large vessels, as well as for treatment of deep vein thrombosis; and FlowTriever, a large bore catheter-based aspiration and mechanical thrombecto...
Analyst Forecast
According to 12 analyst ratings, the average rating for NARI stock is "Hold." The 12-month stock price forecast is $75, which is a decrease of -5.43% from the latest price.
Next Earnings Release
Analysts project revenue of $160.61M, reflecting a 21.59% YoY growth and earnings per share of -0.03, making a -62.50% decrease YoY.
1 week ago · schaeffersresearch.com
Medical Stock Surges to Multi-Year Highs on Acquisition NewsShares of Inari Medical Inc (NASDAQ:NARI) are 21.5% higher in premarket trading, on track to open at nearly $79 amid news that Stryker (SYK) agreed to acquire the medical device maker in an all-cash d...
